Christopher R. Fenimore - 03 Oct 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
SVP Controller
Signature
/s/**Christopher R. Fenimore
Issuer symbol
REGN
Transactions as of
03 Oct 2022
Net transactions value
-$2,422,504
Form type
4
Filing time
05 Oct 2022, 16:10:31 UTC
Previous filing
11 Apr 2022
Next filing
07 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $2,422,504 -3,346 -15% $724.00 18,269 03 Oct 2022 Direct F1
holding REGN Common Stock 1,779 03 Oct 2022 2021 GRAT
holding REGN Common Stock 5,000 03 Oct 2022 2022 GRAT
holding REGN Common Stock 1,480 03 Oct 2022 By 401(k) Plan
holding REGN Common Stock 1,897 03 Oct 2022 By Trust F2
holding REGN Common Stock 1,348 03 Oct 2022 by 2018 GRAT
holding REGN Common Stock 25 03 Oct 2022 by Trust for Daugh
holding REGN Common Stock 25 03 Oct 2022 by Trust for Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.